Rapport Therapeutics, Inc. (RAPP)
31.06
+1.21
(+4.05%)
USD |
NASDAQ |
Oct 09, 14:56
Rapport Therapeutics Price : 31.06 for Oct. 9, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 08, 2026 | 30.62 | 30.62 | 29.45 | 29.85 | 236780.0 |
| Oct 07, 2026 | 30.81 | 31.35 | 30.46 | 30.86 | 314989.0 |
| Oct 06, 2026 | 32.92 | 34.00 | 30.01 | 31.15 | 235744.0 |
| Oct 05, 2026 | 32.22 | 32.70 | 31.53 | 32.19 | 198868.0 |
| Oct 02, 2026 | 33.33 | 34.48 | 31.77 | 32.17 | 277627.0 |
| Oct 01, 2026 | 33.52 | 34.32 | 32.80 | 32.83 | 326777.0 |
| Sep 30, 2026 | 33.17 | 34.05 | 32.62 | 33.60 | 582027.0 |
| Sep 29, 2026 | 33.25 | 33.66 | 32.12 | 33.02 | 626152.0 |
| Sep 28, 2026 | 33.48 | 34.00 | 32.36 | 33.44 | 552307.0 |
| Sep 25, 2026 | 33.80 | 34.89 | 33.05 | 33.91 | 711808.0 |
| Sep 24, 2026 | 34.15 | 34.21 | 31.58 | 33.83 | 848742.0 |
| Sep 23, 2026 | 41.01 | 41.47 | 33.38 | 34.13 | 745549.0 |
| Sep 22, 2026 | 39.97 | 41.55 | 37.94 | 41.47 | 900214.0 |
| Sep 21, 2026 | 40.70 | 42.18 | 39.11 | 39.66 | 616978.0 |
| Sep 18, 2026 | 41.89 | 43.00 | 40.28 | 40.45 | 998059.0 |
| Sep 17, 2026 | 42.13 | 42.90 | 41.39 | 41.95 | 397300.0 |
| Sep 16, 2026 | 42.82 | 43.67 | 41.23 | 41.39 | 387026.0 |
| Sep 15, 2026 | 43.87 | 43.98 | 41.76 | 42.68 | 189313.0 |
| Sep 14, 2026 | 44.30 | 44.90 | 43.36 | 44.00 | 196928.0 |
| Sep 11, 2026 | 44.21 | 44.30 | 43.01 | 43.62 | 251788.0 |
| Sep 10, 2026 | 43.35 | 44.00 | 42.65 | 43.46 | 319265.0 |
| Sep 09, 2026 | 45.17 | 45.42 | 43.13 | 43.88 | 437740.0 |
| Sep 08, 2026 | 45.01 | 47.00 | 44.67 | 46.09 | 489386.0 |
| Sep 04, 2026 | 47.63 | 48.00 | 45.52 | 45.77 | 279885.0 |
| Sep 03, 2026 | 48.85 | 49.14 | 47.08 | 47.65 | 276963.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| ANI Pharmaceuticals, Inc. | 73.91 |
| Corcept Therapeutics, Inc. | 121.28 |
| Veru, Inc. | 2.47 |
| Johnson & Johnson | 259.98 |
| Eli Lilly & Co. | 1174.30 |
Price Related Metrics
| PS Ratio | 69.74 |
| PEG Ratio | -0.4340 |
| Price to Book Value | 3.522 |
| Earnings Yield | -9.79% |
| Market Cap | 1.489B |
| PEGY Ratio | -0.4340 |